← Back to Search

Breathing Techniques + Meditation for COVID-19 Stress Management

Phase 1
Waitlist Available
Led By Santhosshi Narayanan
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 2 months
Awards & highlights

Study Summary

This trial will investigate whether breathing techniques and meditation can help reduce stress and improve lung health for healthcare workers during the COVID-19 pandemic.

Who is the study for?
This trial is for health care workers at MD Anderson Cancer Center who can read and understand English. It's not suitable for those with recent abdominal surgery not cleared for exercise, brain aneurysm or tumor, history of brain bleeding within the last year, epilepsy, or if pregnant.Check my eligibility
What is being tested?
The study explores whether breathing techniques and meditation can reduce stress and improve lung health in healthcare workers during the COVID-19 pandemic. Participants will engage in yoga, complete questionnaires, undergo quality-of-life assessments, and follow a media intervention.See study design
What are the potential side effects?
Since this trial involves non-invasive practices like meditation and yoga rather than medication or medical procedures, significant side effects are unlikely. However, participants may experience mild discomfort from new physical activities.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants Recruited to the Study (Feasibility)
Number of Participants Who Perceived the Intervention as Useful
Secondary outcome measures
Adherence to the Practice
Breath Holding Time
Change in Resilience
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Supportive Care (video, breathing techniques, meditation)Experimental Treatment5 Interventions
Patients view an instructional video on breathing techniques and meditation. Patients then perform breathing techniques over 3 minutes and meditation over 2 minutes BID for 28 days.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Yoga
2008
Completed Phase 3
~3830
Meditation Therapy
2018
N/A
~50

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
2,966 Previous Clinical Trials
1,804,681 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,933,025 Total Patients Enrolled
1 Trials studying Coronavirus Disease
189 Patients Enrolled for Coronavirus Disease
Santhosshi NarayananPrincipal InvestigatorM.D. Anderson Cancer Center
1 Previous Clinical Trials
41 Total Patients Enrolled

Media Library

Breathing Techniques and Meditation Clinical Trial Eligibility Overview. Trial Name: NCT04482647 — Phase 1
Coronavirus Disease Research Study Groups: Supportive Care (video, breathing techniques, meditation)
Coronavirus Disease Clinical Trial 2023: Breathing Techniques and Meditation Highlights & Side Effects. Trial Name: NCT04482647 — Phase 1
Breathing Techniques and Meditation 2023 Treatment Timeline for Medical Study. Trial Name: NCT04482647 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the FDA recognize Meditation Therapy as a legitimate form of treatment?

"The experts at Power have rated the security of Meditation Therapy a 1, since it is currently only in Phase 1 and there's limited data present to confirm its safety or efficacy."

Answered by AI

What is the main purpose of this medical experiment?

"This trial's primary aim is to measure patient enrollment within two months. Secondary endpoints include adherence (defined as 50% of participants engaging with the intervention 3+ times a week in seven days or less), breath holding time, and perceived stress/psychological impact (assessed using Perceived Stress Scale & COVID-19 Stress Questionnaire)."

Answered by AI

Is recruitment for this study still open?

"According to clinicaltrials.gov, this particular research trial is not currently searching for participants; the posting was first made on June 17th 2020 and its last update occurred September 22nd 2022. However, there are 1118 other studies that are presently recruiting patients."

Answered by AI
~21 spots leftby Apr 2025